Elene Paltrinieri Nardi
Biographic Data
| ID | 1777642 |
|---|---|
| NAME | Elene Paltrinieri Nardi |
| GIVEN NAMES | Elene Paltrinieri |
| FAMILY NAME | Nardi |
| SIGNATURE | NARDI E P |
| AFFILIATIONS | Universidade Federal de São Paulo |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 1 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2018 |
| H-INDEX | 1 |
Stakeholder value judgments in decision-making on the incorporation, financing, and allocation of new health technologies in limited-resource settings: A potential Brazilian approach
When incorporating a new health technology requires reducing/eliminating other health programs, financing it through a tax, or having to choose certain age groups (e.g., younger, working people versus older people), respondents are likely to reject it. When offered the choice of limiting the scope of the program (e.g., prevention versus treatment), respondents are likely to favor prevention. This was the first study in Brazil to capture value jud…
Perception of the value of generic drugs in São Paulo, Brazil
The objective of this study was to assess the perceptions of opinion-leaders, patients and their accompanying family members or carers about generic drugs. Three groups of participants were surveyed: (i) 50 customers while they were visiting commercial pharmacies located in São Paulo city, Brazil, (ii) 25 patients and 25 companions while they were waiting at the university outpatient clinic, and (iii) 50 healthcare opinion-leaders from government…
Perceptions of the population regarding generic drugs in Brazil: A nationwide survey
The findings provide a better understanding of Brazilians' perceptions regarding GDs. This should be considered when formulating healthcare policies aiming at improving access to effective and quality drugs, and reduction of health costs
Perception of the value of generic drugs in São Paulo, Brazil
The objective of this study was to assess the perceptions of opinion-leaders, patients and their accompanying family members or carers about generic drugs. Three groups of participants were surveyed: (i) 50 customers while they were visiting commercial pharmacies located in São Paulo city, Brazil, (ii) 25 patients and 25 companions while they were waiting at the university outpatient clinic, and (iii) 50 healthcare opinion-leaders from government…
Perceptions of the population regarding generic drugs in Brazil: A nationwide survey
The findings provide a better understanding of Brazilians' perceptions regarding GDs. This should be considered when formulating healthcare policies aiming at improving access to effective and quality drugs, and reduction of health costs
Perception of the value of generic drugs in São Paulo, Brazil
The objective of this study was to assess the perceptions of opinion-leaders, patients and their accompanying family members or carers about generic drugs. Three groups of participants were surveyed: (i) 50 customers while they were visiting commercial pharmacies located in São Paulo city, Brazil, (ii) 25 patients and 25 companions while they were waiting at the university outpatient clinic, and (iii) 50 healthcare opinion-leaders from government…
Stakeholder value judgments in decision-making on the incorporation, financing, and allocation of new health technologies in limited-resource settings: A potential Brazilian approach
When incorporating a new health technology requires reducing/eliminating other health programs, financing it through a tax, or having to choose certain age groups (e.g., younger, working people versus older people), respondents are likely to reject it. When offered the choice of limiting the scope of the program (e.g., prevention versus treatment), respondents are likely to favor prevention. This was the first study in Brazil to capture value jud…
Medicine (3 works) · Pharmaceutical Economics and Policy (3 works) · Business (2 works) · Family medicine (2 works) · Health Systems, Economic Evaluations, Quality of Life (2 works) · Perception (2 works) · Pharmaceutical industry and healthcare (2 works) · Psychology (2 works) · Actuarial science (1 works) · Advertising (1 works)